These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 3358758)

  • 1. Normalization of liver glucosylceramide levels in the "Gaucher" mouse by phosphatidylserine injection.
    Datta SC; Radin NS
    Biochem Biophys Res Commun; 1988 Apr; 152(1):155-60. PubMed ID: 3358758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake by neuroblastoma cells of glucosylceramide, glucosylceramide glucosidase, its stimulator protein, and phosphatidylserine.
    Datta SC; Snider RM; Radin NS
    Biochim Biophys Acta; 1986 Jul; 877(3):387-98. PubMed ID: 3730407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glucosylceramide and the level of the glucosidase-stimulating proteins.
    Datta SC; Radin NS
    Lipids; 1986 Nov; 21(11):702-9. PubMed ID: 3099116
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biliary excretion of glycolipid in induced or inherited glucosylceramide lipidosis.
    Pentchev PG; Gal AE; Wong R; Morrone S; Neumeyer B; Massey J; Kanter R; Sawitsky A; Brady RO
    Biochim Biophys Acta; 1981 Sep; 665(3):615-8. PubMed ID: 7295755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between enzyme activity and substrate storage in a cell culture model system for Gaucher disease.
    Schueler UH; Kolter T; Kaneski CR; Zirzow GC; Sandhoff K; Brady RO
    J Inherit Metab Dis; 2004; 27(5):649-58. PubMed ID: 15669681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of synthetic and natural glucosylceramides as substrate for glucosylceramidase assay.
    Vaccaro AM; Kobayashi T; Suzuki K
    Clin Chim Acta; 1982 Jan; 118(1):1-7. PubMed ID: 7053901
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucocerebroside storage in normal monocyte cultures.
    Hardy B; Teitelman-Weissman B; Chazan S; Neri A
    Biomed Pharmacother; 1987; 41(1):40-4. PubMed ID: 3607254
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Glucosylceramide and related compounds in normal tissues and in Gaucher disease.
    Suzuki K
    Prog Clin Biol Res; 1982; 95():219-30. PubMed ID: 7122635
    [No Abstract]   [Full Text] [Related]  

  • 9. Glycosphingolipid studies of visceral tissues and brain from type 1 Gaucher disease variants.
    Nilsson O; Grabowski GA; Ludman MD; Desnick RJ; Svennerholm L
    Clin Genet; 1985 May; 27(5):443-50. PubMed ID: 3924448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. L-glucosylceramide: synthesis, properties, and resistance to catabolism by glucocerebrosidase in vitro.
    Gal AE; Pentchev PG; Massey JM; Brady RO
    Proc Natl Acad Sci U S A; 1979 Jul; 76(7):3083-6. PubMed ID: 290986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Animal and cellular models of Gaucher's disease. I. Refractoriness of thio analogs of glucocerebroside to enzymatic hydrolysis.
    Quirk JM; Weis AL; Shapiro D; Brady RO
    Biotechnol Appl Biochem; 1986 Feb; 8(1):96-100. PubMed ID: 3828086
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The fate of glucosylceramide (glucocerebroside) in genetically impaired (lysosomal beta-glucosidase deficient) Gaucher disease diploid human fibroblasts.
    Saito M; Rosenberg A
    J Biol Chem; 1985 Feb; 260(4):2295-300. PubMed ID: 3919000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A specific and potent inhibitor of glucosylceramide synthase for substrate inhibition therapy of Gaucher disease.
    McEachern KA; Fung J; Komarnitsky S; Siegel CS; Chuang WL; Hutto E; Shayman JA; Grabowski GA; Aerts JM; Cheng SH; Copeland DP; Marshall J
    Mol Genet Metab; 2007 Jul; 91(3):259-67. PubMed ID: 17509920
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphatidylcholine synthesis is elevated in neuronal models of Gaucher disease due to direct activation of CTP:phosphocholine cytidylyltransferase by glucosylceramide.
    Bodennec J; Pelled D; Riebeling C; Trajkovic S; Futerman AH
    FASEB J; 2002 Nov; 16(13):1814-6. PubMed ID: 12223447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Studies of the pathogenesis of Gaucher's disease: tissue distribution and biliary excretion of [14C]L-glucosylceramide in rats.
    Tokoro T; Gal AE; Gallo LL; Brady RO
    J Lipid Res; 1987 Aug; 28(8):968-72. PubMed ID: 3668390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitors and stimulators of glucocerebroside metabolism.
    Radin NS
    Prog Clin Biol Res; 1982; 95():357-83. PubMed ID: 6214799
    [No Abstract]   [Full Text] [Related]  

  • 17. The Gaucher mouse: differential action of conduritol B epoxide and reversibility of its effects.
    Stephens MC; Bernatsky A; Burachinsky V; Legler G; Kanfer JN
    J Neurochem; 1978 May; 30(5):1023-7. PubMed ID: 96213
    [No Abstract]   [Full Text] [Related]  

  • 18. In vitro accumulation of glucocerebroside in neuroblastoma cells: a model for study of Gaucher disease pathobiology.
    Prence EM; Chaturvedi P; Newburg DS
    J Neurosci Res; 1996 Feb; 43(3):365-71. PubMed ID: 8714525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lessons from glucosylceramide and Gaucher's disease.
    Luft FC
    J Mol Med (Berl); 1998 Oct; 76(11):723-4. PubMed ID: 9826117
    [No Abstract]   [Full Text] [Related]  

  • 20. Biochemical studies in a patient with subacute neuropathic Gaucher disease without visceral glucosylceramide storage.
    Wenger DA; Roth S; Kudoh T; Grover WD; Tucker SH; Kaye EM; Ullman MD
    Pediatr Res; 1983 May; 17(5):344-8. PubMed ID: 6856396
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.